CNS Pharmaceuticals, Inc. Depreciation
CNS Pharmaceuticals, Inc. (CNSP) reported Depreciation of $13.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- CNS Pharmaceuticals, Inc. depreciation for the quarter ending 2026-06-30 was $11.13K, a 1136.89% increase year-over-year.
- CNS Pharmaceuticals, Inc. depreciation for the quarter ending 2026-03-31 was $1.87K, a 69.82% increase year-over-year.
- CNS Pharmaceuticals, Inc. depreciation for the quarter ending 2025-12-31 was $1.02K, a 3.55% increase year-over-year.
- CNS Pharmaceuticals, Inc. depreciation for the quarter ending 2025-09-30 was $898.00, a 19.57% increase year-over-year.
- CNS Pharmaceuticals, Inc. depreciation for fiscal 2025 was $3.92K, a 18.51% increase from fiscal 2024.
- CNS Pharmaceuticals, Inc. depreciation for fiscal 2024 was $3.31K, a 20.03% decline from fiscal 2023.
- CNS Pharmaceuticals, Inc. depreciation for fiscal 2023 was $4.13K, a 64.83% decline from fiscal 2022.
- CNS Pharmaceuticals, Inc. depreciation for fiscal 2022 was $11.76K, a 10.05% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $11.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $13.00K 10-Q · filed 2026-08-12 | $14.02K derived: sum of 3 quarters · filed 2026-08-12 | $14.92K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $1.87K 10-Q · filed 2026-05-14 | $2.89K derived: sum of 2 quarters · filed 2026-05-14 | $3.79K derived: sum of 3 quarters · filed 2026-05-14 | $4.69K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $1.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.92K derived: sum of 2 quarters · filed 2026-03-31 | $2.82K derived: sum of 3 quarters · filed 2026-08-12 | $3.92K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $898.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.80K derived: sum of 2 quarters · filed 2026-08-12 | $2.90K 10-Q · filed 2025-11-14 | $3.88K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $900.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.00K 10-Q · filed 2026-08-12 | $2.20K 10-Q · filed 2025-08-14 | $2.98K derived: sum of 3 quarters · filed 2026-08-12 | $3.74K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.10K 10-Q · filed 2026-05-14 | $2.08K derived: sum of 2 quarters · filed 2026-05-14 | $2.84K derived: sum of 3 quarters · filed 2026-05-14 | $3.59K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $985.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.74K derived: sum of 2 quarters · filed 2026-03-31 | $2.49K derived: sum of 3 quarters · filed 2026-03-31 | $3.31K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $751.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.50K derived: sum of 2 quarters · filed 2025-11-14 | $2.32K 10-Q · filed 2025-11-14 | $3.27K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $752.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.57K 10-Q · filed 2025-08-14 | $2.52K derived: sum of 3 quarters · filed 2025-08-14 | $3.42K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $818.00 10-Q · filed 2025-05-15 | $1.77K derived: sum of 2 quarters · filed 2025-05-15 | $2.67K derived: sum of 3 quarters · filed 2025-05-15 | $3.67K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $953.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.85K derived: sum of 2 quarters · filed 2025-03-31 | $2.85K derived: sum of 3 quarters · filed 2025-03-31 | $4.13K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $899.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.90K derived: sum of 2 quarters · filed 2024-11-14 | $3.18K 10-Q · filed 2024-11-14 | $5.56K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.28K 10-Q · filed 2024-08-14 | $4.66K derived: sum of 3 quarters · filed 2024-08-14 | $7.46K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $1.28K 10-Q · filed 2024-05-15 | $3.66K derived: sum of 2 quarters · filed 2024-05-15 | $6.45K derived: sum of 3 quarters · filed 2024-05-15 | $9.66K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $2.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.17K derived: sum of 2 quarters · filed 2024-04-01 | $8.38K derived: sum of 3 quarters · filed 2024-04-01 | $11.76K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.00K derived: sum of 2 quarters · filed 2023-11-14 | $9.38K 10-Q · filed 2023-11-14 | $12.87K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $3.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $6.58K 10-Q · filed 2023-08-14 | $10.07K derived: sum of 3 quarters · filed 2023-08-14 | $13.44K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $3.38K 10-Q · filed 2023-05-15 | $6.87K derived: sum of 2 quarters · filed 2023-05-15 | $10.24K derived: sum of 3 quarters · filed 2023-05-15 | $13.45K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $3.49K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $6.86K derived: sum of 2 quarters · filed 2023-03-31 | $10.07K derived: sum of 3 quarters · filed 2023-03-31 | $13.07K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $3.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $6.58K derived: sum of 2 quarters · filed 2022-11-10 | $9.58K 10-Q · filed 2022-11-10 | $12.72K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $3.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $6.21K 10-Q · filed 2022-08-12 | $9.35K derived: sum of 3 quarters · filed 2022-08-12 | $12.52K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-13 | $6.14K derived: sum of 2 quarters · filed 2022-05-13 | $9.30K derived: sum of 3 quarters · filed 2022-05-13 | $12.18K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $3.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $6.31K derived: sum of 2 quarters · filed 2022-03-03 | $9.18K derived: sum of 3 quarters · filed 2022-03-03 | $11.10K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $3.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $6.04K derived: sum of 2 quarters · filed 2021-11-12 | $7.95K 10-Q · filed 2021-11-12 | $9.04K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $2.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $4.79K 10-Q · filed 2021-08-13 | $5.88K derived: sum of 3 quarters · filed 2021-08-13 | $6.58K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $1.92K 10-Q · filed 2021-05-13 | $3.01K derived: sum of 2 quarters · filed 2021-05-13 | $3.71K derived: sum of 3 quarters · filed 2021-05-13 | $3.87K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $1.09K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $1.79K derived: sum of 2 quarters · filed 2021-02-12 | $1.96K derived: sum of 3 quarters · filed 2021-02-12 | $1.96K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $698.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $865.00 derived: sum of 2 quarters · filed 2020-11-12 | $865.00 10-Q · filed 2020-11-12 | $865.00 derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $167.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $167.00 10-Q · filed 2020-08-10 | $167.00 derived: sum of 3 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |